Search
Olema Pharmaceuticals Inc
OLMAAdd to Watchlist
7.560USD
+0.040+0.53%
Close 11-13 16:00（ET）
661.50MMarket Cap
LossP/E TTM
Olema Pharmaceuticals Inc (OLMA) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Olema Pharmaceuticals Inc in the past month.
Buy
4 Strong Buy
7 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
35.444USD+406.35%
OLMA Analyst Recommendation Trends
In the current month, OLMA has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. OLMA average Analyst price target in the last month is 35.444.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
5
5
5
5
7
7
7
7
7
7
7
7
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
12
13
13
13
12
Financial Forecasting
Based on analysts' estimates, OLMA EPS is projected to reach -0.711 in FY2026Q4, following reported EPS of -0.728 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.53
-0.54
-0.62
-0.71
-0.69
Actual
-0.52
-0.61
-0.73
--
--
Surprise
+2.34%
-11.12%
-16.51%
--
--
FAQs
What is Olema Pharmaceuticals Inc's price target?
Analysts forecast that Olema Pharmaceuticals Inc's price target is USD 22.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 18.00.
How have Olema Pharmaceuticals IncOLMA's recent earnings per share performed?
The market expectation was USD -0.73, while Olema Pharmaceuticals IncOLMA's earnings per share (EPS) for the previous quarter was USD -0.61. EPS for the next quarter is expected at USD -0.71.
What is the analyst rating for Olema Pharmaceuticals Inc?
Based on the ratings of Olema Pharmaceuticals Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.